BRCA2 and ovarian cancer: Given current fiscal constraints and the somewhat lower frequency of the Whalsay variant, the immediate recommendation is that testing for BRCA2 c.517-2A>G should be offered to those of Whalsay ancestry with a first-degree relative with breast or ovarian cancer, and, to those with an affected second degree relative connected through an unaffected male.